We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

105 hedge funds and large institutions have $407M invested in Epizyme, Inc in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 19 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

184% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 19

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

7% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 15

1% more funds holding

Funds holding: 104 → 105 (+1)

0% more call options, than puts

Call options by funds: $216K | Put options by funds: $216K

35% less capital invested

Capital invested by funds: $628M → $407M (-$220M)

Holders
105
Holders Change
+1
Holders Change %
+0.96%
% of All Funds
2.34%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
16
Increased
54
Reduced
19
Closed
15
Calls
$216K
Puts
$216K
Net Calls
–
Net Calls Change
+$85K

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$33.5M
2
OM
Opaleye Management
Massachusetts
+$7.06M
3
BlackRock
BlackRock
New York
+$6.34M
4
Millennium Management
Millennium Management
New York
+$5.25M
5
NMC
NEA Management Company
Maryland
+$3.18M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$18.9M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$7.09M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$7.08M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$3.09M
5
UONDDL
University of Notre Dame du Lac
Indiana
-$2.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIM
26
Spark Investment Management
New York
$2.23M +$2.77M +362,600 New
Charles Schwab
27
Charles Schwab
California
$2.04M +$427K +55,974 +20%
UBS Group
28
UBS Group
Switzerland
$1.67M +$1.35M +176,853 +188%
Two Sigma Investments
29
Two Sigma Investments
New York
$1.67M +$1.74M +228,192 +543%
Citadel Advisors
30
Citadel Advisors
Florida
$1.62M +$1.32M +172,515 +190%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.59M +$252K +33,020 +15%
EAM
32
Erste Asset Management
Austria
$1.58M +$2.05M +268,200 New
Hudson Bay Capital Management
33
Hudson Bay Capital Management
Connecticut
$1.39M +$515K +67,473 +43%
Deutsche Bank
34
Deutsche Bank
Germany
$1.38M +$174K +22,743 +11%
Macquarie Group
35
Macquarie Group
Australia
$1.25M – – –
Renaissance Technologies
36
Renaissance Technologies
New York
$1.05M +$1.3M +170,388 New
SCA
37
Secor Capital Advisors
New York
$1.03M +$1.28M +167,035 New
Goldman Sachs
38
Goldman Sachs
New York
$1.02M +$212K +27,820 +20%
Citigroup
39
Citigroup
New York
$1.01M +$960K +125,681 +324%
Bank of America
40
Bank of America
North Carolina
$1.01M +$1.08M +141,324 +640%
PP
41
PDT Partners
New York
$939K +$205K +26,783 +21%
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$779K +$173K +22,700 +22%
TA
43
Teachers Advisors
New York
$680K +$97.5K +12,770 +13%
Jacobs Levy Equity Management
44
Jacobs Levy Equity Management
New Jersey
$668K +$137K +18,000 +20%
Swiss National Bank
45
Swiss National Bank
Switzerland
$636K +$97.8K +12,800 +14%
TCIM
46
TIAA CREF Investment Management
New York
$615K -$7.26K -951 -0.9%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$574K +$110K +14,388 +18%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$551K +$297K +38,852 +77%
WMSA
49
Weiss Multi-Strategy Advisers
New York
$524K +$344K +45,000 +113%
CSS
50
Cubist Systematic Strategies
Connecticut
$494K +$538K +70,406 +725%
1
2
3 4 5

EPZM Hedge Fund Activity: Q4 2018 in Review

105 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q4 2018, worth a combined $407M — down 35% from $628M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new EPZM positions and 15 closed out — a net gain of 1 holder — while 54 added to existing stakes and 19 trimmed.

The largest buyer was Redmile Group, adding an estimated $33.5M. The largest seller was Deerfield Management, exiting entirely with an estimated $18.9M sold.

  • 105 institutional investors held Epizyme, Inc (EPZM) as of Q4 2018, up from 104 in Q3 2018.
  • Funds reported $407M of Epizyme, Inc stock for Q4 2018, down 35% quarter-over-quarter.
  • 16 funds opened new Epizyme, Inc positions in Q4 2018 and 15 closed out, a net change of +1 holder.
  • The largest Epizyme, Inc buyer in Q4 2018 was Redmile Group, an estimated $33.5M added.
  • The largest Epizyme, Inc seller in Q4 2018 was Deerfield Management, an estimated $18.9M sold.

Based on aggregated 13F filings for Q4 2018.